<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="research-article"        dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>j. res. pharm.</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Journal of Research in Pharmacy</journal-title>
            </journal-title-group>
                                        <issn pub-type="epub">2630-6344</issn>
                                                                                            <publisher>
                    <publisher-name>Marmara University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id pub-id-type="doi">10.35333/jrp.2020.200</article-id>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Pharmacology and Pharmaceutical Sciences (Other)</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Eczacılık ve İlaç Bilimleri (Diğer)</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                                                            <article-title>Thin layer chromatography as a simple and quick inprocess tool for qualitative and semi-quantitative determination of unentrapped drugs in liposomal formulations</article-title>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                <name>
                                    <surname>Kumar</surname>
                                    <given-names>Mukesh</given-names>
                                </name>
                                                                    <aff>Department of Pharmaceutics, Y.B Chavan College of Pharmacy</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                <name>
                                    <surname>Lahoti</surname>
                                    <given-names>Swaroop Rameshwarji</given-names>
                                </name>
                                                                    <aff>Department of Pharmaceutics, Y.B Chavan College of Pharmacy</aff>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20250627">
                    <day>06</day>
                    <month>27</month>
                    <year>2025</year>
                </pub-date>
                                        <volume>24</volume>
                                        <issue>4</issue>
                                        <fpage>518</fpage>
                                        <lpage>528</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20200225">
                        <day>02</day>
                        <month>25</month>
                        <year>2020</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20200615">
                        <day>06</day>
                        <month>15</month>
                        <year>2020</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 2010, Journal of Research in Pharmacy</copyright-statement>
                    <copyright-year>2010</copyright-year>
                    <copyright-holder>Journal of Research in Pharmacy</copyright-holder>
                </permissions>
            
                                                                                                                        <abstract><p>Control of free or unentrapped drug is one of the key quality attributes for liposomal drug delivery systems. Conventional methodologies for estimating unentrapped drug in liposomal formulations require prior separation, which are time-consuming and complex. There is a need for a quick in-process analytical technique, which can enable monitoring of drug loading during various stages of product development and manufacturing. A novel simple and rapid TLC procedure was developed for evaluating entrapment efficiency in liposomal formulations. The method is based on differential radial migration of free and entrapped drug on silica gel TLC plates. The method can be employed either as a simple visual qualitative tool in the early screening studies or in a semi-quantitative mode for detection of free and unentrapped drugs. In case of doxorubicin hydrochloride, a deep-red coloured molecule, the method enabled free drug detection up to the levels as low as 2.5%. This method precluded the need of developing the plate further with the mobile phase. The method was used successfully in product development or as an in-process monitoring tool. The method’s potential for characterizing entrapment efficiency was evaluated for less intensely coloured or UV absorbing drug candidates such as amphotericin B liposome and curcumin liposome. The preliminary results post derivatization with ninhydrin reagent or visualization under UV light indicated applicability of technique in general for liposomal delivery systems of various other drugs. According to the best of the author’s knowledge, there has been no reports on the evaluation of drug entrapment using such TLC based technique so far.</p></abstract>
                                                            
            
                                                                                        <kwd-group>
                                                    <kwd>Liposomal formulation</kwd>
                                                    <kwd>  Unentrapped or free drug</kwd>
                                                    <kwd>  Thin layer chromatography</kwd>
                                                    <kwd>  Supramolecular
characterization</kwd>
                                            </kwd-group>
                            
                                                                                                                                                    </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">[1] Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017; 9(2): 12. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">[2] Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine. 2012; 7: 49-60. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">[3] Kapoor M, Lee SL, Tyner KM. Liposomal drug product development and quality: current US experience and perspective. The AAPS Journal. 2017; 19(3): 632-641. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">[4] Allen TM. Liposomal drug formulations. Drugs. 1998; 56(5): 747-756. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">[5] Panwar P, Pandey B, Lakhera PC, Singh KP. Preparation, characterization, and in vitro release study of albendazoleencapsulated nanosize liposomes. Int J Nanomedicine. 2010; 5: 101-108. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">[6] Gabizon AA. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Can. Invest. 2001; 19(4): 424-436. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">[7] Ali MZ, Foad AS, Zarrabi A, Reza TM. Liposomal doxorubicin delivery systems: effects of formulation and processing parameters on drug loading and release behavior. Current Drug Deliv. 2016; 13(7): 1065-1070.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">[8] Szebeni J, Fülöp T, Dézsi L, Metselaar B, Storm G. Liposomal doxorubicin: the good, the bad and the not-so-ugly. J Drug Target. 2016; 24(9): 765-767. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">[9] Chen D, Cole DL, Srivatsa GS. Determination of free and encapsulated oligonucleotides in liposome formulated drug product. J Pharmaceut Biomed. 2000; 22(5): 791-801. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">[10] Mayer LD, Onge GS. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques. Anal Biochem. 1995; 232(2): 149-157. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">[11] Thies RL, Cowens DW, Cullis PR, Bally MB, Mayer LD. Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma. Anal Biochem. 1990; 188(1): 65-71. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">[12] Griese N, Blaschke G, Boos J, Hempel G. Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis. J Chromatogr A. 2002; 979(1-2): 379-388. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">[13] Druckmann S, Gabizon A, Barenholz Y. Separation of liposome-associated doxorubicin from non-liposomeassociated doxorubicin in human plasma: implications for pharmacokinetic studies. Biochim Biophys Acta. 1989; 980(3): 381-384. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref14">
                        <label>14</label>
                        <mixed-citation publication-type="journal">[14] Edwards KA, Baeumner AJ. Analysis of liposomes. Talanta. 2006; 68(5): 1432-1441. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref15">
                        <label>15</label>
                        <mixed-citation publication-type="journal">[15] Gomez-Hens A, Fernandez-Romero JM. Analytical methods for the control of liposomal delivery systems. Trend Anal Chem. 2006; 25(2): 167-178. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref16">
                        <label>16</label>
                        <mixed-citation publication-type="journal">[16] Dipali SR, Kulkarni SB, Betagiri GV. Comparative study of separation of non‐ encapsulated drug from unilamellar liposomes by various methods. J Pharm Pharmacol. 1996; 48(11): 1112-1115. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref17">
                        <label>17</label>
                        <mixed-citation publication-type="journal">[17] Yamamoto E, Miyazaki S, Aoyama C, Kato M. A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography. Int J Pharm. 2018; 536(1): 21-28. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref18">
                        <label>18</label>
                        <mixed-citation publication-type="journal">[18] Dhanesar SC, Peeler TR, Engel BS. Evaluation of phospholipids in liposomes by HPTLC. J Planar Chromat. 1992; 5(1): 45-49.</mixed-citation>
                    </ref>
                                    <ref id="ref19">
                        <label>19</label>
                        <mixed-citation publication-type="journal">[19] Holzer M, Burghardt A, Schubert R. Quantitative high-performance thin-layer chromatography determination of common liposome components and critical parameters influencing the analysis results. J Liposome Res. 2010; 20(2): 124-133. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref20">
                        <label>20</label>
                        <mixed-citation publication-type="journal">[20] Hatziantoniou S, Demetzos C. Method of simultaneous analysis of liposome components using HPTLC/FID. In: D’Souza (Eds). Liposomes. Humana Press, New York, NY, USA, 2010, pp. 363-368. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref21">
                        <label>21</label>
                        <mixed-citation publication-type="journal">[21] Hatziantoniou S, Demetzos C. Method of simultaneous analysis of liposome components using HPTLC/FID. In: D’Souza (Eds). Liposomes. Humana Press, New York, NY, USA, 2017, pp. 49-54 [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref22">
                        <label>22</label>
                        <mixed-citation publication-type="journal">[22] Brailoiu E, Saila L, Huhurez G, Costuleanu M, Filipeanu CM, Slatineanu S, Cotrutz C, Branisteanu DD. TLC—A rapid method for liposome characterization. BMC. 1994; 8(4): 193-195. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref23">
                        <label>23</label>
                        <mixed-citation publication-type="journal">[23] Brailoiu E, Huhurez G, Slatineanu S, Filipeanu CM, Costuleanu M, Branisteanu DD. TLC characterization of liposomes containing D‐ myo‐ inositol derivatives. BMC. 1995; 9(4): 175-178. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref24">
                        <label>24</label>
                        <mixed-citation publication-type="journal">[24] Brailoiu E, Beschea C, Brailoiu C, Costuleanu A, Filipeanu CM, Costuleanu M, Fallgrens B, Branisteanu DD. TLC Characterization of Small Unilamellar Liposomes Containing D‐ myo‐ Inositol Derivatives. BMC. 1996; 10(5): 233- 236. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref25">
                        <label>25</label>
                        <mixed-citation publication-type="journal">[25] Van Renswoude AJ, Blumenthal R, Weinstein JN. Thin-layer chromatography with agarose gels: A quick, simple method for evaluating liposome size. Biochim Biophys Acta. 1980; 595(1): 151-156. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref26">
                        <label>26</label>
                        <mixed-citation publication-type="journal">[26] Nicoletti M. HPTLC fingerprint: a modern approach for the analytical determination of botanicals. Rev Bras Farmacogn. 2011; 21(5): 818-823. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref27">
                        <label>27</label>
                        <mixed-citation publication-type="journal">[27] Ansari MJ, Ahmad S, Kohli K, Ali J, Khar RK. Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations. J PharmBiomed. 2005; 39(1-2): 132-138. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref28">
                        <label>28</label>
                        <mixed-citation publication-type="journal">[28] Fritze A, Hens F, Kimpfler A, Schubert R, Peschka-Süss R. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim Biophys Acta. 2006; 1758(10): 1633-1640. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref29">
                        <label>29</label>
                        <mixed-citation publication-type="journal">[29] Sarfraz M, Afzal A, Yang T, Gai Y, Raza SM, Khan MW, Cheng Y, Ma X, Xiang G. Development of dual drug loaded nanosized liposomal formulation by a reengineered ethanolic injection method and its pre-clinical pharmacokinetic studies. Pharmaceutics. 2018; 10(3): 151. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref30">
                        <label>30</label>
                        <mixed-citation publication-type="journal">[30] IB times (2017). India suspends licences of 10 drug firms over product quality, safety issues. Accessed on 25th January, 2020. http://www.ibtimes.co.in/india-suspends-licences-10-drug-firms-over-product-quality-safety-issues-678258 (Accessed on 25th January 2020).</mixed-citation>
                    </ref>
                                    <ref id="ref31">
                        <label>31</label>
                        <mixed-citation publication-type="journal">[31] Sainz V, Conniot J, Matos AI, Peres C, Zupanǒiǒ E, Moura L, Silva LC, Florindo HF, Gaspar RS. Regulatory aspects on nanomedicines. Biochem Biophys Res. 2015; 468(3): 504-510. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref32">
                        <label>32</label>
                        <mixed-citation publication-type="journal">[32] Wang JP, Maitani Y, Takayama K, Nagai T. Pharmacokinetics and antitumor effect of doxorubicin carried by stealth and remote loading proliposome. Pharm Res. 2000; 17(7): 782-787. [CrossRef]</mixed-citation>
                    </ref>
                                    <ref id="ref33">
                        <label>33</label>
                        <mixed-citation publication-type="journal">[33] Patel NA, Patel NJ, Patel RP. Formulation and evaluation of curcumin gel for topical application. Pharm Dev Technol. 2009; 14(1): 83-92. [CrossRef]</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
